A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence. LJMHR [Internet]. 2024 Jul. 8 [cited 2026 Feb. 2];24(6):63-87. Available from: https://journalspress.uk/index.php/LJMHR/article/view/920